LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6–RUNX1: concordant results using quantitation of fusion transcript and flow cytometry

Photo from wikipedia

The translocation t(12;21)(p13;q22) resulting in the fusion gene ETV6–RUNX1, is the most frequent gene fusion in childhood B lymphoblastic leukemia. In the Nordic Society of Paediatric Haematology and Oncology ALL‐2008… Click to show full abstract

The translocation t(12;21)(p13;q22) resulting in the fusion gene ETV6–RUNX1, is the most frequent gene fusion in childhood B lymphoblastic leukemia. In the Nordic Society of Paediatric Haematology and Oncology ALL‐2008 treatment protocol, treatment stratification in B‐lineage ALL is based on results of minimal residual disease (MRD) analysis with fluorescence‐activated cell sorting (FACS). In this study, we determined whether RT‐qPCR of the ETV6–RUNX1 fusion transcript can be a reliable alternative for MRD analysis.

Keywords: etv6 runx1; minimal residual; p13 q22; lymphoblastic leukemia; childhood lymphoblastic; fusion

Journal Title: International Journal of Laboratory Hematology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.